Care
Also: Wysa receives FDA Breakthrough Device Designation for its mental health chatbot, and Pear Therapeutics expands its telehealth partnership program.
The company said it would use the Series A to expand its team, build its provider network, and add partnerships with health systems and payers.
The startup also announced a new product called Clear Contracts that aims to improve the direct contracting process.
HIMSS22
Grace Cordovano, founder of Enlightening Results, explains how the Unblock Health patient advocacy movement helps patients managing a cancer or chronic illness diagnosis with their administrative burden.
Also: Precision oncology platform OncoHost scores $35 million, home care startup Reverence emerges from stealth with $9.5 million and pediatric behavioral health startup Handspring Health completes a $6.2 million seed round.
The companies said their long-term goal is to develop and offer more digital health tools "through a multi-partner ecosystem" as well as advocate for reimbursement options.
HIMSS22
“Mental filters” have throttled people's intake of facts about health, according to Denise Scannell, chief scientist of health communication at MITRE.
The funding will also go toward attracting leadership talent and accelerating product development, marketing and sales.
The digital mental health unicorn confirmed it received a grand jury subpoena from the U.S. Attorney's Office for the Eastern District of New York on the evening of May 4.
The clearance represents what could be the world's first regulatory approval of a DTx app for hypertension treatment.